Posted by yxibow on February 22, 2008, at 2:38:29
In reply to Re: Budeprion (Generic) vs. Wellbutrin, posted by pollyjean on February 18, 2008, at 18:06:03
There are few compounds that are sensitive enough for individuals generally to detect between generic and patented. Also there are a few compounds that are required to be especially monitored.
There are other issues -- there can be a placebo effect when one knows they're using generic medication. This is not entirely baseless.
Some generics, little known are actually made by a subsidiary of their own original patented company. Gabapentin (Greenstone brand) is made by Greenstone, a generic subsidiary of Pfizer, the original maker of Neurontin.
The most important thing with generics if one really finds they actually have sustained differences is attempting to insist on obtaining the same generic brand from the pharmacy. Some pharmacies may change suppliers from time to time which is based on their own cost issues. This may result in having to fill it at another pharmacy if one needs this route.
Finally, generally things like propranolol, diazepam, and the like have been generic for years, used generically in hospitals, and it is far expensive to get the few remaining "originals" of Xanax, Klonopin, and Valium.
Patent regulations and years are different in Canada and there is already generic Seroquel (Cipla) in Canada. There is also a provision in the US for "hostile" or non-notifying of application for generic. Teva is currently trying to apply for generic Seroquel, which may cost them patent infringement fees but could come to market. I'm not a lawyer so I don't quite understand these provisions but these things have happened apparently.
Just a view-- Jay
poster:yxibow
thread:397165
URL: http://www.dr-bob.org/babble/20080221/msgs/814044.html